Allen Hester

4.5k total citations · 1 hit paper
26 papers, 3.1k citations indexed

About

Allen Hester is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Allen Hester has authored 26 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Allen Hester's work include Blood Pressure and Hypertension Studies (14 papers), Heart Failure Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (7 papers). Allen Hester is often cited by papers focused on Blood Pressure and Hypertension Studies (14 papers), Heart Failure Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (7 papers). Allen Hester collaborates with scholars based in United States, Sweden and Italy. Allen Hester's co-authors include Michael A. Weber, George L. Bakris, Kenneth Jamerson, Eric J. Velazquez, Victor Shi, Bertram Pitt, Björn Dahlöf, Marjorie Gatlin, Robert Glazer and Jay N. Cohn and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Allen Hester

25 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

2008 1.3k citations Kenneth Jamerson, Michael A. Weber et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allen Hester United States	19	2.6k	949	483	398	232	26	3.1k
Steffan Ekman Switzerland	11	2.6k 1.0×	1.2k 1.3×	728 1.5×	324 0.8×	301 1.3×	15	3.1k
Robert Glazer United States	26	2.9k 1.1×	652 0.7×	533 1.1×	152 0.4×	192 0.8×	50	3.3k
Jean‐Pierre Boissel France	22	1.7k 0.6×	458 0.5×	513 1.1×	254 0.6×	96 0.4×	53	2.9k
Ettore Ambrosioni Italy	28	2.6k 1.0×	654 0.7×	448 0.9×	304 0.8×	128 0.6×	117	3.2k
Jeong Bae Park South Korea	32	1.8k 0.7×	789 0.8×	522 1.1×	330 0.8×	154 0.7×	109	3.4k
José L. Cangiano Puerto Rico	14	1.1k 0.4×	481 0.5×	280 0.6×	409 1.0×	126 0.5×	35	2.2k
Seung Hwan Han South Korea	36	1.7k 0.6×	1.2k 1.3×	1.5k 3.2×	287 0.7×	212 0.9×	127	4.0k
Leanne Dyal Canada	15	1.9k 0.7×	1.3k 1.4×	659 1.4×	193 0.5×	264 1.1×	24	3.2k
Patricia R. Hebert United States	23	1.4k 0.5×	499 0.5×	900 1.9×	294 0.7×	232 1.0×	49	3.0k
Roberto Marchioli Italy	21	926 0.4×	560 0.6×	652 1.3×	1.4k 3.4×	126 0.5×	38	3.2k

Countries citing papers authored by Allen Hester

Since Specialization

Citations

This map shows the geographic impact of Allen Hester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Hester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Hester more than expected).

Fields of papers citing papers by Allen Hester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Hester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Hester. The network helps show where Allen Hester may publish in the future.

Co-authorship network of co-authors of Allen Hester

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Hester. A scholar is included among the top collaborators of Allen Hester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Hester. Allen Hester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Bryan, John R. Cockcroft, Kazuomi Kario, et al.. (2014). Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study. BMJ Open. 4(2). e004254–e004254. 42 indexed citations

Bakris, George L., Αlexandros Briasoulis, Björn Dahlöf, et al.. (2013). Comparison of Benazepril Plus Amlodipine or Hydrochlorothiazide in High-Risk Patients With Hypertension and Coronary Artery Disease. The American Journal of Cardiology. 112(2). 255–259. 15 indexed citations

Weber, Michael A., George L. Bakris, Allen Hester, et al.. (2013). Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension. The American Journal of Medicine. 126(6). 501–508. 41 indexed citations

Shah, Amil M., Sung‐Hee Shin, Madoka Takeuchi, et al.. (2011). Left Ventricular Systolic and Diastolic Function, Remodelling, and Clinical Outcomes Among Patients with Diabetes Following Myocardial Infarction and the Influence of Direct Renin Inhibition with Aliskiren. European Journal of Heart Failure. 14(2). 185–192. 38 indexed citations

Kjeldsen, Sverre E., Kenneth Jamerson, George L. Bakris, et al.. (2011). Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study. Blood Pressure. 21(2). 82–87. 5 indexed citations

Weber, Michael A., George L. Bakris, Kenneth Jamerson, et al.. (2010). Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes. Journal of the American College of Cardiology. 56(1). 77–85. 139 indexed citations

Kjeldsen, Sverre E., Kenneth Jamerson, George L. Bakris, et al.. (2008). Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study. Blood Pressure. 17(1). 7–17. 32 indexed citations

Satterlee, D.G., et al.. (2008). Influences of Maternal Corticosterone and Selection for Contrasting Adrenocortical Responsiveness in Japanese Quail on Developmental Instability of Female Progeny. Poultry Science. 87(8). 1504–1509. 17 indexed citations

Jamerson, Kenneth, Michael A. Weber, George L. Bakris, et al.. (2008). Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. New England Journal of Medicine. 359(23). 2417–2428. 1313 indexed citations breakdown →

10.

Weber, Michael A., George L. Bakris, Björn Dahlöf, et al.. (2007). Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk. Blood Pressure. 16(1). 13–19. 47 indexed citations

11.

Jamerson, Kenneth, George L. Bakris, Björn Dahlöf, et al.. (2007). Exceptional early blood pressure control rates: The ACCOMPLISH trial. Blood Pressure. 16(2). 80–86. 103 indexed citations

12.

Majahalme, Silja, Lawrence Baruch, Nora Aknay, et al.. (2005). Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial). The American Journal of Cardiology. 95(4). 529–532. 20 indexed citations

13.

Majani, Giuseppina, Anna Giardini, Cristina Opasich, et al.. (2005). Effect of Valsartan on Quality of Life When Added to Usual Therapy for Heart Failure: Results From The Valsartan Heart Failure Trial. Journal of Cardiac Failure. 11(4). 253–259. 45 indexed citations

14.

Anand, Inder S., Roberto Latini, Viorel G. Florea, et al.. (2005). C-Reactive Protein in Heart Failure. Circulation. 112(10). 1428–1434. 360 indexed citations

15.

Anand, Inder S., Michael A. Kuskowski, Thomas S. Rector, et al.. (2005). Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure. Circulation. 112(8). 1121–1127. 212 indexed citations

16.

Anand, Inder S., Joseph Yen, Viorel G. Florea, et al.. (2004). 1163-121 Prognostic role of neutrophil and lymphocyte counts in heart failure: Results from Val-HeFT. Journal of the American College of Cardiology. 43(5). A229–A229. 1 indexed citations

17.

Wong, Maylene, Lidia Staszewsky, Roberto Latini, et al.. (2004). Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure. Journal of the American College of Cardiology. 43(11). 2022–2027. 172 indexed citations

18.

Baruch, Lawrence, Robert Glazer, Nora Aknay, et al.. (2004). Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT). American Heart Journal. 148(6). 951–957. 28 indexed citations

19.

Cohn, Jay N., Gianni Tognoni, Robert Glazer, Dirk Spormann, & Allen Hester. (1999). Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. Journal of Cardiac Failure. 5(2). 155–160. 116 indexed citations

20.

Oparil, Suzanne, et al.. (1996). The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. Clinical Therapeutics. 18(5). 797–810. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact